Page last updated: 2024-08-21

s,n,n'-tripropylthiocarbamate and Pulmonary Disease, Chronic Obstructive

s,n,n'-tripropylthiocarbamate has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erdei, T; Gesztelyi, R; Juhasz, B; Kardos, L; Pak, K; Papp, C; Seres, I; Szentpéteri, A; Szilasi, M; Zsuga, J1
Altet Gómez, N; Barrueco Ferrero, M; de Granda Orive, JI; Jiménez-Ruiz, CA; Lorza Blasco, JJ; Martinez Muñiz, MA; Ramos Pinedo, A; Riesco Miranda, JA; Signes-Costa Miñana, J; Solano Reina, S1

Other Studies

2 other study(ies) available for s,n,n'-tripropylthiocarbamate and Pulmonary Disease, Chronic Obstructive

ArticleYear
Alteration of the irisin-brain-derived neurotrophic factor axis contributes to disturbance of mood in COPD patients.
    International journal of chronic obstructive pulmonary disease, 2017, Volume: 12

    Topics: Affect; Aged; Brain; Brain-Derived Neurotrophic Factor; Chi-Square Distribution; Cross-Sectional Studies; Depression; Female; Fibronectins; Forced Expiratory Volume; Humans; Linear Models; Lung; Male; Middle Aged; Multivariate Analysis; Pulmonary Disease, Chronic Obstructive; Quality of Life; Respiratory Function Tests; Reward; Risk Factors; Signal Transduction; Surveys and Questionnaires

2017
Treatment of smoking in smokers with chronic obstructive pulmonary disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
    Archivos de bronconeumologia, 2013, Volume: 49, Issue:8

    Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Motivation; Multicenter Studies as Topic; Program Evaluation; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Reward; Severity of Illness Index; Smoking; Smoking Cessation; Spain; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2013